Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
557.60
Change Change %
5.75 1.04%

Updated:10 Dec, 2019, 15:44 PM IST

BSE
558.95
Change Change %
6.05 1.09%

Updated:10 Dec, 2019, 15:46 PM IST

Alembic Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'19
(₹ Cr.)
MAR'18
(₹ Cr.)
Change %
Gross Sales 3,660.27 2,945.26 24.28%
Less :Inter divisional transfers 0.00 0.00 0.00%
Less: Sales Returns 0.00 0.00 0.00%
Less: Excise 0.00 0.63 -100.00%
Net Sales 3,660.27 2,944.63 24.30%
EXPENDITURE:
Increase/Decrease in Stock -80.42 -36.18 -122.28%
Raw Materials Consumed 1,080.49 928.91 16.32%
Power & Fuel Cost 88.44 70.21 25.96%
Employee Cost 684.45 582.72 17.46%
Other Manufacturing Expenses 254.55 226.57 12.35%
General and Administration Expenses 319.33 269.55 18.47%
Selling and Distribution Expenses 422.79 273.56 54.55%
Miscellaneous Expenses 31.35 30.68 2.18%
Expenses Capitalised 0.00 0.00 0.00%
Total Expenditure 2,800.98 2,346.02 19.39%
PBIDT (Excl OI) 859.29 598.61 43.55%
Other Income 25.80 40.59 -36.44%
Operating Profit 885.09 639.20 38.47%
Interest 14.87 2.22 569.82%
PBDT 870.22 636.98 36.62%
Depreciation 105.59 101.76 3.76%
Profit Before Taxation & Exceptional Items 764.63 535.22 42.86%
Exceptional Income / Expenses 0.00 0.00 0.00%
Profit Before Tax 764.63 535.22 42.86%
Provision for Tax 153.42 113.23 35.49%
PAT 611.21 421.99 44.84%
Extraordinary Items 0.00 0.00 0.00%
Adj to Profit After Tax -1.90 -3.05 37.70%
Profit Balance B/F 919.76 691.58 32.99%
Appropriations 1,529.07 1,110.52 37.69%
Equity Dividend (%) 275.00 200.00 37.50%
Earnings Per Share (in ₹) 32.42 22.39 44.84%
Book Value (in ₹) 143.89 116.43 23.59%
Top